120
Participants
Start Date
March 9, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Lofexidine
BID dosing, and a max daily dose of 1.6 mg/day
Placebo oral tablet
Placebo
RECRUITING
Michael E. DeBakey Veterans Affairs Medical Center, Houston
RECRUITING
South Texas Veterans Health Care System, San Antonio
United States Department of Defense
FED
RTI International
OTHER
Michael E. DeBakey VA Medical Center
FED
USWM, LLC (dba US WorldMeds)
INDUSTRY
Foundation for Advancing Veterans' Health Research
OTHER
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
OTHER